C74.90
BillableMalignant neoplasm of unsp part of unspecified adrenal gland
Malignant neoplasm of unspecified part of unspecified adrenal gland
Also Known As / Clinical Terms
SNOMED CT
- Primary malignant neoplasm of adrenal gland93665005
- Cancer metastatic to adrenal gland94161006
- Metastasis to adrenal gland94161006
- Metastatic malignant neoplasm of adrenal gland94161006
- Metastatic malignant neoplasm to adrenal gland94161006
- Secondary malignant neoplasm of adrenal gland94161006
- Suprarenal metastasis94161006
- Neuroblastoma of brain281560004
- Adrenal neuroblastoma281562007
- Thoracic neuroblastoma281563002
- Pelvic neuroblastoma281564008
- Abdominothoracic neuroblastoma281566005
- Adrenal gland malignancy363355002
- Cancer of adrenal gland363355002
- Malignant neoplasm of adrenal gland363355002
- Malignant tumor of adrenal gland363355002
- Malignant tumour of adrenal gland363355002
- INSS stage finding -International neuroblastoma staging system stage finding409721000
- International neuroblastoma staging system stage finding409721000
- International neuroblastoma staging system stage 1409722007
- International neuroblastoma staging system stage 2A409723002
- International neuroblastoma staging system stage 2B409724008
- International neuroblastoma staging system stage 3409725009
- International neuroblastoma staging system stage 4409726005
- International neuroblastoma staging system stage 4S409727001
- International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma (Schwannian stroma-dominant) maturing, or mature409729003
- International neuroblastoma pathology classification finding409731007
- International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed (Schwannian stroma-rich)409732000
- International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma (Schwannian stroma-poor), and low or intermediate mitosis-karyorrhexis index409733005
- International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index409734004
- International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor)409735003
- International neuroblastoma pathology classification: Unfavourable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor)409735003
- International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index409736002
- International neuroblastoma pathology classification: Unfavourable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index409736002
- International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index409737006
- International neuroblastoma pathology classification: Unfavourable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index409737006
- International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index409738001
- International neuroblastoma pathology classification: Unfavourable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index409738001
- International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI409739009
- International neuroblastoma pathology classification: Unfavourable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI409739009
- Neuroblastoma432328008
- Aldosterone-producing carcinoma703306007
- Hyperaldosteronism due to carcinoma703306007
- Primary hyperaldosteronism due to aldosterone-secreting malignant neoplasm of adrenal gland703306007
- Metastatic neuroblastoma704152002
- Neuroblastoma of central nervous system734099007
- Metastatic neuroblastoma of abdominothoracic structure1251445000
- Metastatic neuroblastoma to abdominothoracic structure1251445000
- Secondary neuroblastoma of abdominothoracic structure1251445000
- Metastatic neuroblastoma of adrenal gland1251454002
- Metastatic neuroblastoma to adrenal gland1251454002
- Secondary neuroblastoma of adrenal gland1251454002
- Metastatic neuroblastoma of brain1251456000
- Metastatic neuroblastoma to brain1251456000
- Secondary neuroblastoma of brain1251456000
- Metastatic neuroblastoma of central nervous system1251457009
- Metastatic neuroblastoma to central nervous system1251457009
- Secondary neuroblastoma of central nervous system1251457009
- Metastatic neuroblastoma of thorax1251458004
- Metastatic neuroblastoma to thorax1251458004
- Secondary neuroblastoma of thorax1251458004
- Metastatic neuroblastoma of paraspinal area1251459007
- Metastatic neuroblastoma to paraspinal area1251459007
- Secondary neuroblastoma of paraspinal area1251459007
- Metastatic neuroblastoma of pelvis1251460002
- Metastatic neuroblastoma to pelvis1251460002
- Secondary neuroblastoma of pelvis1251460002
- Primary adrenal neuroblastoma1259426006
- Primary neuroblastoma1268519001
Frequently Asked Questions
What is the ICD-10 code for malignant neoplasm of unsp part of unspecified adrenal gland?
The ICD-10-CM code for malignant neoplasm of unsp part of unspecified adrenal gland is C74.90. The full clinical description is "Malignant neoplasm of unspecified part of unspecified adrenal gland". C74.90 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code C74.90 mean?
ICD-10-CM code C74.90 represents "Malignant neoplasm of unspecified part of unspecified adrenal gland". It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.
Is C74.90 a billable code?
Yes, C74.90 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is C74.90 in?
C74.90 is in Chapter 2: Neoplasms (codes C00-D49).
What SNOMED CT codes does C74.90 map to?
C74.90 maps to 38 SNOMED CT concepts: 281566005, 363355002, 281562007, 703306007, 94161006, and 33 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for C74.90?
C74.90 is linked to 1 UMLS Concept Unique Identifier: C2845946. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.